The Office of Infectious Diseases (OID) consists of three review divisions: The Division of Anti-Infectives (DAI), the Division of Antivirals (DAV), and the Division of Pharm/Tox for Infectious Diseases (DPT-ID). The Immediate office oversees the development, review, and regulation of applications as well as issues related to toxicology for drug and biologic products reviewed in these divisions.
Director: John Farley, M.D., MPH
Deputy Director: TBD
Associate Director for Research: Thushi Amini, Ph.D.
Associate Director for Regulatory Science: Sunita Shukla, Ph.D., M.P.H.
Division of Anti-Infective (DAI)
Director: Sumathi Nambiar, M.D., M.P.H.
Deputy Director: Dmitri Iarikov, M.D., Ph.D.
Regulatory Operations Chief Project Managers: Maureen Dillon-Parker and Carmen DeBellas
Division of Antiviral (DAV)
Director: Debra Birnkrant, M.D.
Deputy Director: Jeffery Murray, M.D., M.P.H
Regulatory Operations Chief Project Manager: Karen Winestock
Division of Transplant and Ophthalmology Products (DTOP)
The Division of Ophthalmology will be part of the Office of Specialty Medicine beginning in mid-Jan 2020. For more information, please visit: Reorganization of the Office of New Drugs with Corresponding Changes to the Office of Translational Sciences and the Office of Pharmaceutical Quality.
Director: Ozlem Belen, M.D (Acting)
Deputy Director: Wiley Chambers, M.D.
Overview of research needs, requests for information (RFIs), public workshops/meetings, opportunities for collaboration, externally awarded research studies, and other important research.
Food and Drug Administration
Center for Drug Evaluation and Research
Office of Infectious Diseases
10903 New Hampshire Avenue
Silver Spring, MD 20993
Phone: (301) 796-1300
Fax: (301) 796-9887
Resources For You
- OID Regulatory Science Activities
- Regulators in EU, Japan and US Take Steps to Converge on Approaches to Development of New Antibacterial Drugs
- FDA-Recognized Antimicrobial Susceptibility Test Interpretive Criteria
- Antimicrobial Resistance Information for Consumers and Health Professionals
- Tropical Disease Priority Review Voucher Program
- OID Research Activities
- February 2018 HHS Report to Congress on Generating Antibiotic Incentives Now (GAIN)